Finerenone Treatment Slows Chronic Kidney Disease Progression After Heart Failure Hospitalization
Results from a post hoc subgroup analysis of the FIDELITY study revealed patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) treated with finerenone had slower CKD progression—as measured by estimated glomerular filtration rate (eGFR)— …